• Home
  • Product
  • About
  • Careers
  • News
  • Contact Us
The Baltimore Sun’s 25 Women to Watch 2021: Best in advocacy, business and health (Baltimore Sun staff)

The Baltimore Sun’s 25 Women to Watch 2021: Best in advocacy, business and health (Baltimore Sun staff)

by NovelDX | Nov 1, 2021 | News

The Baltimore Sun’s 25 Women to Watch 2021: Best in advocacy, business and health (Baltimore Sun staff) Andrea Pais is the co-founder and CEO of Novel Microdevices, a developer of diagnostic testing systems. (PHOTO by Lloyd Fox/Baltimore Sun)  Growing up in South...

Carb-X announces up to $13.8m funding for STIs diagnostic

by NovelDX | Apr 8, 2021 | News

Novel Microdevices, Inc. awarded up to $13.8 million from CARB-X for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections

by NovelDX | Apr 6, 2021 | News

Medical Device Accelerator Launchport Adds Tenants

by NovelDX | Feb 26, 2021 | News

Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center

by NovelDX | Feb 26, 2021 | News

Startup Novel Microdevices Developing Rapid Point-of-Care MDx System for STIs

by NovelDX | May 24, 2019 | News

« Older Entries

Recent Posts

  • The Baltimore Sun’s 25 Women to Watch 2021: Best in advocacy, business and health (Baltimore Sun staff)
  • Carb-X announces up to $13.8m funding for STIs diagnostic
  • Novel Microdevices, Inc. awarded up to $13.8 million from CARB-X for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections
  • CARB-X Funding Announcement
  • Medical Device Accelerator Launchport Adds Tenants

Recent Comments

    • Home
    • Product
    • About Us
    • Careers
    • News
    • Contact
    NOVEL MICRODEVICES

    6200 Seaforth St
    Baltimore, MD 21224

    Ph: (443) 312-5488

    Copyright © 2022 Novel DX – All Rights Reserved.